Editorial
Copyright ©2012 Baishideng Publishing Group Co.
World J Radiol. Jan 28, 2012; 4(1): 1-12
Published online Jan 28, 2012. doi: 10.4329/wjr.v4.i1.1
Figure 3
Figure 3 Selected magnetic resonance-guided images showing the advancement of a passive injecting catheter (arrowheads) in the left ventricle prior to (A) and after injecting dysprosium-chelate (T2* enhancing agent) magnetic resonance contrast medium (B, arrowhead) to ensure delivery in the targeted myocardium.